Skip to main content
Orexo logo

Orexo — Investor Relations & Filings

Ticker · ORX ISIN · SE0000736415 LEI · 549300LJ5CCWDPTK9Z08 ST Manufacturing
Open in API
Filings indexed 843 across all filing types
Latest filing 2010-05-05 Interim / Quarterly Rep…
Country SE Sweden
Listing ST ORX

About Orexo

https://orexo.com/

Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2010
Interim / Quarterly Report Classification · 1% confidence The document is a 'delårsrapport' (interim report) for Orexo AB covering the period January-March 2010. It contains comprehensive financial statements, including income statements, cash flow analysis, and management commentary on business performance, risks, and financial position. It is not an announcement of a report, but the report itself, and it provides substantive financial data for a period shorter than a full fiscal year. Q1 2010
2010-05-05 Swedish
Interim / Quarterly Report 2010
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim report, January-March 2010' for Orexo AB. It contains comprehensive financial statements, including a condensed consolidated statement of operations, revenue breakdowns, expense analysis, and a discussion of the company's financial position for the specified quarter. It is not an announcement of a report, but the report itself, containing substantive financial data and management analysis for an interim period. Q1 2010
2010-05-05 English
AGM Information 2010
AGM Information Classification · 1% confidence The document is explicitly titled 'Report from Orexo AB's Annual General Meeting, April 21, 2010'. It details resolutions passed regarding the re-election of the Board of Directors, approval of financial statements, director fees, and the adoption of a board member share plan. These are the core activities and outcomes of an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R). The document length (4472 chars) is substantial enough to be the report itself, not just an announcement of the report.
2010-04-21 English
AGM Information 2010
AGM Information Classification · 1% confidence The document is explicitly titled 'Kommuniké från Orexo AB:s årsstämma den 21 april 2010' (Communiqué from Orexo AB's Annual General Meeting on April 21, 2010). It details decisions made during the AGM, including the approval of financial statements, election of board members, setting board remuneration, and approving a shareholder program. This content directly corresponds to the definition of AGM Information (AGM-R). Although it contains elements related to remuneration (DEF 14A) and board structure (MANG/CGR), the overarching context is the official summary of the Annual General Meeting proceedings.
2010-04-21 Swedish
Annual Report 2009
Annual Report Classification · 1% confidence The document is titled 'Årsredovisning 2009' (Annual Report 2009) and contains comprehensive financial statements, management reports, notes, and auditor reports for the fiscal year 2009. It follows the standard structure of a full annual report, including the CEO's commentary, business model, project portfolio, and detailed financial tables (balance sheets, income statements, cash flow). It is clearly the full annual report, not an announcement or summary. FY 2009
2010-04-07 Swedish
Capital/Financing Update 2010
Capital/Financing Update Classification · 1% confidence The document is a press release dated April 7, 2010, announcing the completion of a significant transaction involving a convertible bond issue and the acquisition of existing shares by Novo A/S. This transaction resulted in a change in the board of directors (election of Michael Shalmi). The content focuses on financing/capital structure changes (bond issue, share acquisition) and subsequent board changes. Since the primary event is the completion of a financing/capital transaction, the most fitting primary category is 'Capital/Financing Update' (CAP). Although it mentions a board change (MANG), the context is directly tied to the completion of the financing deal. Given the nature of the announcement (a specific corporate action related to capital), CAP is preferred over the general MANG announcement, and it is not a general regulatory filing (RNS) because it fits a specific category.
2010-04-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.